In the ’90s, Dr. Neila Cortes-Maramba of UP Manila led a team of scientists investigating ten medicinal plants in the Philippines. Two of these plants exhibited promising results—one for cough and the other for urinary tract infections. The team patented Vitex negundo (Lagundi) and Blumea balsamifera (Sambong) in syrup and tablet forms, granting them exclusive rights to these medicines.

Today, Lagundi and Sambong are essential remedies for coughs and UTIs, proving lucrative for the pharmaceutical industry. Had they not applied for a patent, UP Manila and its partners would not have earned more than 50 million pesos in remittances through royalties and licensing fees, nor would they have been able to claim the invention as their own and would leave it vulnerable to idea theft.

If inventions and creations are not patented, “it belongs now to the public domain where anyone can reproduce or manufacture it,” Atty. Josephine R. Santiago of the UP Diliman College of Law said at the 7th session of the iStories webinar, hosted by the University of the Philippines – Diliman College of Science. Atty. Santiago is an award-winning intellectual property (IP) expert who served as the Director General of the Intellectual Property Office of the Philippines (IPOPHL).

By: Harvey L. Sapigao